Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

PCVX holding history

Vaxcyte, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PCVX overviewAll 13F holders of PCVXFull Q2 2026 holdings

Shares (Q2 2026)
21,990
Value
$1.28M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of PCVX by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202621,990$1.28M<0.1%−2,459−10.1%ReducedHolders
Q1 202624,449$1.42M<0.1%−2,276−8.5%ReducedHolders
Q4 202526,725$1.23M<0.1%+2,524+10.4%AddedHolders
Q3 202524,201$871.7K<0.1%−6,408−20.9%ReducedHolders
Q2 202530,609$995.1K<0.1%−2,083−6.4%ReducedHolders
Q1 202532,692$1.23M<0.1%−8,183−20.0%ReducedHolders
Q4 202440,875$3.35M<0.1%+11,729+40.2%AddedHolders
Q3 202429,146$3.33M<0.1%+8,212+39.2%AddedHolders
Q2 202420,934$1.58M<0.1%−5,733−21.5%ReducedHolders
Q1 202426,667$1.82M<0.1%+5,060+23.4%AddedHolders
Q4 202321,607$1.36M<0.1%+3,285+17.9%AddedHolders
Q3 202318,322$934.1K<0.1%+302+1.7%AddedHolders
Q2 202318,020$899.9K<0.1%+4,030+28.8%AddedHolders
Q1 202313,990$524.3K<0.1%−1,770−11.2%ReducedHolders
Q4 202215,760$755.7K<0.1%+4,833+44.2%AddedHolders
Q3 202210,927$262.0K<0.1%+464+4.4%AddedHolders
Q2 202210,463$228.0K<0.1%−3,364−24.3%ReducedHolders
Q1 202213,827$334.0K<0.1%−2,428−14.9%ReducedHolders
Q4 202116,255$387.0K<0.1%−72−0.4%ReducedHolders
Q3 202116,327$414.0K<0.1%−3,217−16.5%ReducedHolders
Q2 202119,544$440.0K<0.1%+4,750+32.1%AddedHolders
Q1 202114,794$292.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.